TR200003082T2 - Genel endişe bozukluğunun paroksetin ile tedavisi - Google Patents

Genel endişe bozukluğunun paroksetin ile tedavisi

Info

Publication number
TR200003082T2
TR200003082T2 TR2000/03082T TR200003082T TR200003082T2 TR 200003082 T2 TR200003082 T2 TR 200003082T2 TR 2000/03082 T TR2000/03082 T TR 2000/03082T TR 200003082 T TR200003082 T TR 200003082T TR 200003082 T2 TR200003082 T2 TR 200003082T2
Authority
TR
Turkey
Prior art keywords
treatment
paroxetine
anxiety disorder
general anxiety
general
Prior art date
Application number
TR2000/03082T
Other languages
English (en)
Turkish (tr)
Inventor
Zaninelli Rocco
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200003082T2 publication Critical patent/TR200003082T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR2000/03082T 1998-04-22 1999-04-22 Genel endişe bozukluğunun paroksetin ile tedavisi TR200003082T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9808479.1A GB9808479D0 (en) 1998-04-22 1998-04-22 Method of treatment

Publications (1)

Publication Number Publication Date
TR200003082T2 true TR200003082T2 (tr) 2001-01-22

Family

ID=10830715

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03082T TR200003082T2 (tr) 1998-04-22 1999-04-22 Genel endişe bozukluğunun paroksetin ile tedavisi

Country Status (20)

Country Link
EP (1) EP1073437A4 (cs)
JP (1) JP2002512189A (cs)
KR (1) KR20010034817A (cs)
CN (1) CN1298301A (cs)
AP (1) AP2000001959A0 (cs)
AU (1) AU3864899A (cs)
BG (1) BG104939A (cs)
BR (1) BR9909791A (cs)
CA (1) CA2328896A1 (cs)
CZ (1) CZ20003885A3 (cs)
EA (1) EA200001088A1 (cs)
GB (1) GB9808479D0 (cs)
HU (1) HUP0101350A3 (cs)
ID (1) ID27546A (cs)
IL (1) IL139167A0 (cs)
NO (1) NO20005286L (cs)
PL (1) PL343494A1 (cs)
SK (1) SK15672000A3 (cs)
TR (1) TR200003082T2 (cs)
WO (1) WO1999053919A1 (cs)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
PL343494A1 (en) 2001-08-27
EP1073437A1 (en) 2001-02-07
CA2328896A1 (en) 1999-10-28
CZ20003885A3 (cs) 2001-09-12
IL139167A0 (en) 2001-11-25
GB9808479D0 (en) 1998-06-17
BR9909791A (pt) 2000-12-26
AP2000001959A0 (en) 2000-12-31
HUP0101350A2 (hu) 2002-05-29
NO20005286L (no) 2000-12-20
EP1073437A4 (en) 2003-04-16
NO20005286D0 (no) 2000-10-20
CN1298301A (zh) 2001-06-06
JP2002512189A (ja) 2002-04-23
WO1999053919A1 (en) 1999-10-28
ID27546A (id) 2001-04-12
KR20010034817A (ko) 2001-04-25
SK15672000A3 (sk) 2001-04-09
BG104939A (bg) 2001-09-28
HUP0101350A3 (en) 2002-06-28
AU3864899A (en) 1999-11-08
EA200001088A1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
TR200201887T2 (tr) Sulu elastomer kaplama bileşimi ve bununla kaplanmış cisimler.
TR199801302T2 (xx) �kame edilmi� aza ve diazasikolopentan ve siklooktan bile�ikleri.
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
BR0111298A (pt) Moduladores seletivos dos receptores de andrógenos e métodos para identificação, projeto e uso dos mesmos
ATE447561T1 (de) Substituierte aryl 1,4-pyrazin derivate
CY1105758T1 (el) Τροποποιημενη απιμιναση αργινινης
TR199801390T2 (xx) Tromboz tedavisinde kullan�lacak p�ht�la�may� �nleyici maddeler
DK0889886T5 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
TR200002616T2 (tr) Simetrik ve simetrik olmayan sübstitüe edilmiş difenil üreler kullanılarak raf kinazın inhibe edilmesi
TR199501441A2 (tr) Islevsel poliorganosiloksanlar ve bunlarin hazirlanmasina mahsus islemlerden bir tanesi.
TR199901572T2 (xx) Transdermal terap�tik sistem.
DK0998460T3 (da) Hidtil ukendte tetrazolderivater
TR200002860T2 (tr) Bir antiviral benzimidazol terkibin yeni kristal formları.
DK0827537T3 (da) Chromatin-regulator-gener
ATE224351T1 (de) Trisubstituierte phenyl derivate mit retinoid agonist, antagonist oder inversagonist biologischer aktivität
DE59905233D1 (de) Polyadditionen in wässrigen und nichtwässrigen miniemulsionen
TR199802704T2 (xx) H�V tedavisinde Vx478, Zidov�din, FTC ve/veya 3TC i�eren kombinasyonlar�n kullan�m�.
DE59909760D1 (de) Benzonaphthyridin-n-oxide mit pde3 und pde4 inhibierender aktivität
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
DK1540335T3 (da) Screeningsfremgangsmåder til kognitive forstækere
TR200002072T2 (tr) Spiropiperidin türevleri
TR199900943T2 (xx) Pirimidin t�revlerinin haz�rlanma prosesi.
TR199801988T2 (xx) Kalp yetmezli�inin endotelin antagonistleri ile tedavisi i�in y�ntem.
TR200003082T2 (tr) Genel endişe bozukluğunun paroksetin ile tedavisi
PT1143917E (pt) Derivados anticonvulsionantes uteis no tratamento da perturbacao de stress pos-traumatico